(Q44920667)

English

Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

author name string

C Dittrich

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

R Jakesz

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

K Pirich

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

L Havelec

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

G Steger

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

O Schlappack

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

R Kolb

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

K Moser

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

113

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

488-494

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

https://scigraph.springernature.com/pub.10.1007/bf00390044

0 references

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The enigmatic behavior of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer consensus

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy in breast cancer—Swiss co-operative studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of patients with disseminated cancer of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of metastasizing breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and pred

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival after first recurrence in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant systemic therapy for resectable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Number of lymph nodes examined and the prognosis of breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Adjuvant chemotherapy in breast cancer: status in 1984]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival after recurrence of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral adjuvant therapy in breast carcinoma—a multicentre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Adjuvant chemotherapy of breast neoplasms. Review of the up-to-date results of various studies including the Heidelberg study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3624302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00390044

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44920667&oldid=2057035836"